SensUs

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
SensUs Student Competition
Logo SensUs
Contest dateSeptember 3rd, 2021
FrequencyAnnual
LocationEindhoven, The Netherlands
First year2016
Contactcontact@sensus.org
Websitewww.sensus.org
Livestreamdigital.sensus.org
PhotosFlickr
VideosYoutube

SensUs [1] is the annual international student competition on molecular biosensors for health.[a 1] Multidisciplinary student teams from universities worldwide design and build biosensing systems, and demonstrate their prototypes and business models during a final public contest event. The competition stimulates education and innovation in the field of biosensing, with a worldwide scope. The long term aim is to improve the quality of life of patients.

Approach of the competition[edit]

Each year, SensUs addresses a different healthcare theme and a corresponding biomarker. The participating teams develop sensors for measuring the selected biomarker. The teams have the same functional end goal, but develop creative solutions and unique biosensor prototypes. The prototypes are shown, demonstrated and discussed at the annual SensUs contest. The teams also develop corresponding business models. SensUs is an international platform for learning and innovation in the field of molecular biosensors for healthcare applications.

During the SensUs contest, the teams and their biosensors are judged by an international, multidisciplinary jury. The jury gives awards for Analytical Performance (AP), Creativity (CR), and Translational Potential (TP). Furthermore, a Public Inspiration (PI) award is conferred by the public. The public can vote from all over the world, on the teams that they think are most inspiring.

This year[edit]

SensUs 2021[edit]

SensUs 2021 focuses on acute respiratory viruses. The international Teams will develop innovative biosensing systems to detect influenza A in saliva, in the form of inactive viruses. For more information about influenza, see the following link: [2].

On the 3rd of September, 2021, the Teams will present their innovative biosensors during the SensUs Event 2021.[2]

History[edit]

SensUs 2020[edit]

On the 28th of August 2020 the fifth edition of SensUs Student Competition took place. 15 international student teams developed biosensors for the measurement of unbound valproate, a biological drug that is used to treat epilepsy. Epilepsy is a chronic neurological disease that affects about 50 million people worldwide and is characterized by recurrent seizures.

Due to COVID-19, the final Event was organized in a fully digital manner. 8.000 people voted and there were 15.000 website-and livestream users from all over the world.  [3]

A list of the participating universities and the results in SensUs 2020 can be found below.[4]

Participating universities[edit]

Team University Country Awards
EpiSense KU Leuven Belgium 1st TP
BiosensUM Université de Montréal Canada
TruSense Zhejiang University China 1st PI
DeTectUs Technical University of Denmark Denmark
AUSense American University in Cairo Egypt 2nd PI
Minerva Imperial College London England
AixSense RWTH Aachen Germany
T.E.S.T Eindhoven University of Technology The Netherlands 1st CR[5]
UT+ University of Twente The Netherlands
LxUs University of Lisbon Portugal 2nd TP
SenseNC North Carolina State University United States of America
SenseGlasgow University of Glasgow Scotland
SensingBarcelona Polytechnic University of Catalonia & University of Vic & University of Barcelona Spain
UppSense Uppsala University Sweden 2nd CR
Helvet'Sens École Polytechnique Fédérale de Lausanne Switzerland

The Analytical Performance Award was not awarded in this edition, since the laboratories for most of the Teams were closed due to Covid-19.

SensUs 2019[edit]

SensUs Event 2019

The theme of SensUs 2019 was "Managing rheumatic disease, by measuring with ease".[6] The disease focus was Rheumatoid Arthritis and the molecule to be detected was Adalimumab.

Adalimumab is a biological drug that binds to TNF-alpha, a pro-inflammatory cytokine. The overexpression of this cytokine plays an important role in rheumatoid arthritis. Many patients do not respond to treatment with Adalimumab or lose response during treatment. A biosensor for Adalimumab could detect this at an early stage and help save unnecessary costs. Worldwide annual sales of Adalimumab are more than 10 billion US dollars.[7] The finals of SensUs 2019 took place on the 30th of August 2019 in Eindhoven, the Netherlands. More than 10.000 people voted and the cumulative online visitor count was 22.000 from over 80 countries. Photos of SensUs 2019 can be found here

A list of the participating universities and the results in SensUs 2019 can be found below.

Participating teams and results[edit]

Team University Country Awards
SynoSense[8] KU Leuven Belgium 1st TP
BiosensUM[9] Université de Montréal Canada 2nd CR
TruSense[10] Zhejiang University China 2nd PI
DeTectUs[11] Technical University of Denmark Denmark
AUSense[12] American University in Cairo Egypt 2nd AP
Joint Venture[13] Imperial College London England
AixSense[14] RWTH Aachen Germany 1st PI
T.E.S.T.[15] Eindhoven University of Technology The Netherlands 1st AP 1st CR
LxUs[16] University of Lisbon Portugal
SenseNC[17] North Carolina State University United States of America
Glasensor[18] University of Glasgow Scotland
SensingBarcelona[19] Polytechnic University of Catalonia & University of Vic Spain
AdUpSense[20] Uppsala University Sweden
EPFSens[21] École Polytechnique Fédérale de Lausanne Switzerland 2nd TP

SensUs 2018[edit]

On the 7th and 8th of September 2018, the finals of the third edition of the SensUs Student Competition took place in Eindhoven, the Netherlands. The theme was “Measuring antibiotics for better healthcare”. The teams developed biosensors for the detection of vancomycin, an important last resort antibiotic drug.[22]

The Teams tested vancomycin in blood plasma and pitched the business models that they had developed. The public votes were cast on the online platform called SensUs Digital.[23] More than 10.000 users watched SensUs via the digital platform and 3750 people cast their votes. In parallel, a competition was held for teams of High school students. Photos of SensUs 2018 can be found here.

Participating teams and results[edit]

Team University Country Awards
SensImperial Imperial College London England
AIXSense RWTH Aachen University Germany
DeTectUs Technical University of Denmark Denmark
VanGow University of Glasgow Scotland 1st CR 2nd AP
VancoSense KU Leuven Belgium 1st TP
SenseNC North Carolina State University United States of America
American University in Cairo The American University in Cairo Egypt 1st PI
T.E.S.T. Eindhoven University of Technology The Netherlands 2nd PI
U.V.S. Uppsala University Sweden
SenSwiss École Polytechnique Fédérale de Lausanne Switzerland 1st AP 2nd CR 2nd TP
BiosensUM Université de Montreal Canada
TruSense Zhejiang University China
UScience Tech Barcelona Polytechnic University of Catalonia & University of Vic Spain

SensUs 2017[edit]

SensUs 2017 was the second edition of the competition. The finals of SensUs 2017 took place on the 8th and 9th of September 2017.[24] Ten student teams from three continents built biosensors to detect NT-proBNP in blood plasma, which is an important biomarker for Heart failure.[25] During the Event the Teams showed their biosensors to the public, measured NT-proBNP live and presented pitches on technology and on translation to society.

About 500 people visited the Event at Eindhoven University of Technology. The Event was broadcast on the SensUs Digital platform,[26] including livestreams, live data, Q&A, photos and videos and voting functionality. The cumulative visitor count on SensUs digital was 5000 from 74 countries, of which 1500 people cast their votes for the Public Inspiration award (PI). Photos of SensUs 2017 can be found here.

Participating teams and results[edit]

Team University Country Awards
IC SensUs Imperial College London England
SensAble University of Applied Sciences Kaiserslautern Germany
DeTectUs Technical University of Denmark Denmark 2nd CR 2nd PI
GlasGo University of Glasgow Scotland
Carediobit KU Leuven Belgium 2nd AP 2nd TP
SenseNC North Carolina State University United States of America
AUC Imhoteps The American University in Cairo Egypt
T.E.S.T. Eindhoven University of Technology The Netherlands 1st AP 1st TP 1st PI
UppSense Uppsala University Sweden 1st CR
Swissense École Polytechnique Fédérale de Lausanne Switzerland

SensUs 2016[edit]

SensUs 2016 was the first edition of the SensUs Competition. The aim was to develop biosensors for the measurement of creatinine in blood plasma, which is a key biomarker for Kidney failure. The student teams originated from five universities: University of Leuven, Imperial College London, Uppsala University, Technical University of Denmark and Eindhoven University of Technology. The teams had worked during 9 months to develop biosensors in their own universities, and thereafter all came to the SensUs Event on the 9th and 10th of September 2016 at Eindhoven University of Technology. Photos and videos from SensUs 2016 can be found here.

Participating teams and results[edit]

Team University Country Awards
SensUpp Uppsala University Sweden
KreaSensa KU Leuven Belgium AP TP PI
Creative9 Technical University of Denmark Denmark
IC SensUs Imperial College London England
T.E.S.T. Eindhoven University of Technology The Netherlands CR

Notes[edit]

  1. ^ A biosensor is a compact device that interacts with a biological system to acquire a signal for diagnostic or monitoring purposes. A molecular biosensor is a biosensor with a molecular interaction as a central aspect. It is an analytical device with a molecular recognition element and with a transduction principle that turns the biomolecular interaction into a measurable signal. Molecular biosensors operate on samples taken from the body (in-vitro testing e.g. using a drop of blood) or are worn on or inside the body (for real-time in-vivo sensing).

References[edit]

  1. ^ "SensUs | Let's compete for quality of life!". SensUs.
  2. ^ "SensUs Event 2021". www.sensus.org. Retrieved 2020-10-24.
  3. ^ "Studentencompetitie SensUs zet in op biosensor voor betere dosering epilepsiemedicijn". Innovation Origins (in Dutch). 2020-09-04. Retrieved 2020-10-24.
  4. ^ "Teams 2021". www.sensus.org. Retrieved 2020-10-24.
  5. ^ "Science is here: Science is here #5: SensUs and biosensors with Menno Prins and Jesse Jägers". scienceishere.libsyn.com. Retrieved 2020-10-24.
  6. ^ "Snellere dosering reumamedicijn dichterbij door studentencompetitie SensUs". Innovation Origins (in Dutch). 2019-06-25. Retrieved 2020-10-24.
  7. ^ "Adalimumab". September 24, 2020 – via Wikipedia.
  8. ^ "SynoSense". www.sensus.org.
  9. ^ "BiosensUM". www.sensus.org.
  10. ^ [1][dead link]
  11. ^ "DeTectUs". www.sensus.org.
  12. ^ "AUSense". www.sensus.org.
  13. ^ "Joint Venture". www.sensus.org.
  14. ^ "AixSense". www.sensus.org.
  15. ^ "T.E.S.T." www.sensus.org.
  16. ^ "LxUs". www.sensus.org.
  17. ^ "SenseNC". www.sensus.org.
  18. ^ "Glasensor". www.sensus.org.
  19. ^ "SensingBarcelona". www.sensus.org.
  20. ^ "AdUp Sense". www.sensus.org.
  21. ^ "EPFSens". www.sensus.org.
  22. ^ "SensUs 2018". www.sensus.org.
  23. ^ "SensUs - Home". digital.sensus.org.
  24. ^ "SensUs 2017 ― Visitors, votes and winners". www.sensus.org.
  25. ^ "Problem 2017: Heart Failure". www.sensus.org.
  26. ^ SensUs Digital (2017)

External links[edit]